Abstract: Technologies are described herein for providing dynamic natural language interactions between a user and a computing device. In one aspect, a computing device managing a conversation with a user is enhanced with the identification and management of one or more topics. Using techniques described herein, the computing device can focus on one or more topics, shift between topics and/or introduce new topics. Techniques disclosed herein may also manage and process interruptions that may be introduced during a conversation. Dynamic access of contextual information may assist in the generation of contextually-relevant statements, and the contextual information may be used to balance priorities between various topics. Each topic may also have an associated decay rate so that the lifespan of individual topics may track realistic scenarios. In addition, the priorities of individual topics may be dynamically adjusted so topics may track events created by a user and a computing device.

Abstract: The present invention relates to compounds of Formula P-I where the variables (e.g. R1, Y, A, R1, Ra, Ra?, Rb, Rb?, Rc, Rc?, Rd, Rd?, Re, or Re?) and compositions useful for inhibiting and/or reducing platelet deposition, adhesion and/or aggregation. The present invention further relates to methods for the treatment or prophylaxis of thrombotic disorders, including stroke, myocardial infarction, unstable angina, peripheral vascular disease, abrupt closure following angioplasty or stent placement and thrombosis as a result of vascular surgery.

Abstract: The present invention relates to compounds and compositions of Formula P useful for inhibiting and/or reducing platelet deposition, adhesion and/or aggregation. The definitions of variables A, B, R2, R3, R4, Ra, Ra?, Rb, Rb?, Rc, Rd, Rd?, Re, and Re? are provided in the disclosure. The present invention further relates to methods for the treatment or prophylaxis of thrombotic disorders, including stroke, myocardial infarction, unstable angina, peripheral vascular disease, abrupt closure following angioplasty or stent placement and thrombosis as a result of vascular surgery.

Abstract: Technologies are described herein for providing dynamic natural language interactions between a user and a computing device. In one aspect, a computing device managing a conversation with a user is enhanced with the identification and management of one or more topics. Using techniques described herein, the computing device can focus on one or more topics, shift between topics and/or introduce new topics. Techniques disclosed herein may also manage and process interruptions that may be introduced during a conversation. Dynamic access of contextual information may assist in the generation of contextually-relevant statements, and the contextual information may be used to balance priorities between various topics. Each topic may also have an associated decay rate so that the lifespan of individual topics may track realistic scenarios. In addition, the priorities of individual topics may be dynamically adjusted so topics may track events created by a user and a computing device.

Abstract: The present invention relates to compounds and compositions useful for inhibiting and/or reducing platelet deposition, adhesion and/or aggregation. The present invention further relates to methods for the treatment or prophylaxis of thrombotic disorders, including stroke, myocardial infarction, unstable angina, peripheral vascular disease, abrupt closure following angioplasty or stent placement and thrombosis as a result of vascular surgery.

Abstract: The present invention relates to compounds of formula P-1 and related compounds and compositions useful for inhibiting and/or reducing platelet deposition, adhesion and/or aggregation. The definitions of A, Y, R1, R2, Ra, Ra?, Rb, Rb?, Rc, Rc?, Rd, Rd?, Re, and Re? are provided herein. The present invention further relates to methods for the treatment or prophylaxis of thrombotic disorders, including stroke, myocardial infarction, unstable angina, peripheral vascular disease, abrupt closure following angioplasty or stent placement and thrombosis as a result of vascular surgery.

Abstract: The present invention relates to compounds and compositions useful for inhibiting and/or reducing platelet deposition, adhesion and/or aggregation. The present invention further relates to a drug-eluting stent comprising said compounds and methods for the treatment or prophylaxis of thrombotic disorders, including stroke, myocardial infarction, unstable angina, peripheral vascular disease, abrupt closure following angioplasty or stent placement and thrombosis as a result of vascular surgery.

Abstract: The present invention relates to compounds and compositions useful for inhibiting and/or reducing platelet deposition, adhesion and/or aggregation. The present invention further relates to methods for the treatment or prophylaxis of thrombotic disorders, including stroke, myocardial infarction, unstable angina, peripheral vascular disease, abrupt closure following angioplasty or stent placement and thrombosis as a result of vascular surgery.